enow.com Web Search

  1. Ads

    related to: vascepa alternatives for dogs

Search results

  1. Results from the WOW.Com Content Network
  2. Ethyl eicosapentaenoic acid - Wikipedia

    en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

    Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL. Further, it is often required to be used with a statin (maximally ...

  3. Non-surgical fertility control for dogs and cats - Wikipedia

    en.wikipedia.org/wiki/Non-surgical_fertility...

    Non-surgical fertility control is the prevention of reproduction without the use of surgery. The most common form of sterilization in dogs and cats is surgical, spaying in females and castration in males. Non-surgical fertility control can either result in sterilization or temporary contraception and could offer a cheaper way to keep wild dog ...

  4. Pimobendan - Wikipedia

    en.wikipedia.org/wiki/Pimobendan

    Pimobendan (INN, or pimobendane), sold under the brand name Vetmedin among others, is a veterinary medication. It is a calcium sensitizer and a selective inhibitor of phosphodiesterase 3 (PDE3) with positive inotropic and vasodilator effects. Pimobendan is used in the management of heart failure in dogs, most commonly caused by myxomatous ...

  5. Fish oil - Wikipedia

    en.wikipedia.org/wiki/Fish_oil

    Vascepa is not approved as a monotherapy for lowering TGs: it must be taken with a statin, per product labeling. [81] Some fish-oil products are approved for parenteral nutrition: Omegaven, approved in July 2018, is indicated as a source of calories and fatty acids in children with parenteral nutrition-associated cholestasis (PNAC). [82] [83] [84]

  6. Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ...

    lite.aol.com/tech/story/0022/20240822/9218601.htm

    DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded subgroup data from the landmark REDUCE-IT ® cardiovascular outcomes trial with VASCEPA ® /VAZKEPA ® (icosapent ethyl), as well as abstracts showcasing the mechanistic activity of eicosapentaenoic acid (EPA) that will be presented at the ...

  7. Amarin Given 3-Year Exclusivity for Vascepa - AOL

    www.aol.com/2014/02/21/amarin-given-3-year...

    The FDA awarded the firm three years of marketing exclusivity for Vascepa capsules. That approval expires in. Amarin has received an important approval from the Food and Drug Administration, but ...

  1. Ads

    related to: vascepa alternatives for dogs